ZA856862B - Process for preparation of a solid form for oral use based on nifedipine with controlled release of the active substance - Google Patents

Process for preparation of a solid form for oral use based on nifedipine with controlled release of the active substance

Info

Publication number
ZA856862B
ZA856862B ZA856862A ZA856862A ZA856862B ZA 856862 B ZA856862 B ZA 856862B ZA 856862 A ZA856862 A ZA 856862A ZA 856862 A ZA856862 A ZA 856862A ZA 856862 B ZA856862 B ZA 856862B
Authority
ZA
South Africa
Prior art keywords
nifedipine
preparation
active substance
controlled release
oral use
Prior art date
Application number
ZA856862A
Other languages
English (en)
Inventor
Vittorio Giudice
Vittorino Ravelli
Original Assignee
Pharmatec Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11199169&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA856862(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmatec Spa filed Critical Pharmatec Spa
Publication of ZA856862B publication Critical patent/ZA856862B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Cosmetics (AREA)
  • Electroplating And Plating Baths Therefor (AREA)
  • Surgical Instruments (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Steering Control In Accordance With Driving Conditions (AREA)
ZA856862A 1984-09-14 1985-09-06 Process for preparation of a solid form for oral use based on nifedipine with controlled release of the active substance ZA856862B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22678/84A IT1178511B (it) 1984-09-14 1984-09-14 Procedimento per la preparazione di una forma solida per uso orale a base di nifedipina con rilascio

Publications (1)

Publication Number Publication Date
ZA856862B true ZA856862B (en) 1986-05-28

Family

ID=11199169

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA856862A ZA856862B (en) 1984-09-14 1985-09-06 Process for preparation of a solid form for oral use based on nifedipine with controlled release of the active substance

Country Status (16)

Country Link
EP (1) EP0226588B1 (xx)
JP (1) JPS62500660A (xx)
AT (1) ATE61733T1 (xx)
AU (1) AU588258B2 (xx)
CA (1) CA1253079A (xx)
DE (1) DE3582251D1 (xx)
DK (1) DK172710B1 (xx)
ES (1) ES8702137A1 (xx)
FI (1) FI87991C (xx)
IE (1) IE58490B1 (xx)
IT (1) IT1178511B (xx)
NO (1) NO171887C (xx)
PT (1) PT81113B (xx)
WO (1) WO1986001717A1 (xx)
YU (1) YU45988B (xx)
ZA (1) ZA856862B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
SE8601624D0 (sv) * 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
DK173505B1 (da) * 1987-02-20 2001-01-15 Pharmatec Internat S R L Fremgangsmåde til fremstilling af en diltiazempellet med langsom afgivelse og anvendelse af således fremstillede pelleter t
GB8722306D0 (en) * 1987-09-22 1987-10-28 Aps Research Ltd Sustained-release formulation
GB8903328D0 (en) * 1989-02-14 1989-04-05 Ethical Pharma Ltd Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
HU203041B (en) * 1989-03-14 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
US5122384A (en) * 1989-05-05 1992-06-16 Kv Pharmaceutical Company Oral once-per-day organic nitrate formulation which does not induce tolerance
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
WO1994005262A1 (en) * 1992-09-10 1994-03-17 F.H. Faulding & Co. Limited Sustained release matrix composition
US6077533A (en) * 1994-05-25 2000-06-20 Purdue Pharma L.P. Powder-layered oral dosage forms
US7060293B1 (en) 1994-05-25 2006-06-13 Purdue Pharma Powder-layered oral dosage forms
DE59410044D1 (de) * 1994-12-29 2002-03-21 Shire Deutschland Gmbh & Co Kg Pharmazeutische zubereitungen, enthaltend nifedipin und verfahren zu ihrer herstellung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453642A1 (fr) * 1979-04-12 1980-11-07 Sanofi Sa Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotoxine
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
DE3433239A1 (de) * 1984-09-11 1986-03-20 Bayer Ag, 5090 Leverkusen Feste arzneizubereitung enthaltend nitrendipin und verfahren zu ihrer herstellung
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation

Also Published As

Publication number Publication date
DK222186D0 (da) 1986-05-13
IT8422678A0 (it) 1984-09-14
IE852262L (en) 1986-03-14
FI87991C (fi) 1993-03-25
WO1986001717A1 (en) 1986-03-27
FI871116A0 (fi) 1987-03-13
IT1178511B (it) 1987-09-09
IE58490B1 (en) 1993-09-22
DK222186A (da) 1986-05-13
NO861845L (no) 1986-05-07
NO171887C (no) 1993-05-19
JPS62500660A (ja) 1987-03-19
AU588258B2 (en) 1989-09-14
YU143985A (en) 1987-10-31
JPH0417932B2 (xx) 1992-03-26
CA1253079A (en) 1989-04-25
DK172710B1 (da) 1999-06-07
DE3582251D1 (de) 1991-04-25
NO171887B (no) 1993-02-08
AU4959485A (en) 1986-04-08
EP0226588B1 (en) 1991-03-20
PT81113B (pt) 1987-10-20
ATE61733T1 (de) 1991-04-15
EP0226588A1 (en) 1987-07-01
ES547707A0 (es) 1987-01-16
FI871116A (fi) 1987-03-13
YU45988B (sh) 1992-12-21
FI87991B (fi) 1992-12-15
PT81113A (en) 1985-10-01
ES8702137A1 (es) 1987-01-16

Similar Documents

Publication Publication Date Title
DE3465599D1 (en) Addition compounds suited as dispersing agents, process for their preparation, their use and solid materials coated with them
ZA856862B (en) Process for preparation of a solid form for oral use based on nifedipine with controlled release of the active substance
IE812075L (en) Composition
EP0336205A3 (en) Process for the preparation of isocyanuratepolyisocyanates, the compounds obtained according to this process and their use
DE10075031I2 (de) Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs.
EP0456062A3 (en) Process for preparation of isocyanuratepolyisocyanates, the compounds prepared according to this process, and their use
PT82129B (en) Process for the preparation of macroemulsions containing at least one solid pyrethroid as active ingredient
HUT39568A (en) Insecticide and acaricide compositions containing 13beta-alkyl-milbemycin derivatives as active ingredients further process for preparing the active substances
GB2128092B (en) Stabilized insecticidal composition and process for the preparation thereof
EP0375184A3 (en) Composition and use
AU587626B2 (en) Continuous release peptide composition
HUT41224A (en) Herbicide compositions containing n-aryl-triazole derivatives as active substances and process for preparing the active substances
HUT37710A (en) Insecticide and fungicide composition containing azolyl-propanol derivatives as active substances and process for preparing the active substances
IL64416A (en) N-cyclopropyloxyphenyl-n'-benzoylurea derivatives,process for the preparation thereof and insecticidal compositions containing them
AU552347B2 (en) Controlled release particulate fertilizer composition
AU4545289A (en) 2-azabicyclo(2.2.1)hept-5-ene-2-acetic acid, derivatives thereof and related compounds, process for the preparation of said compounds and the use of said compounds for the manufacture of n-phosphonomethylglycine
EP0351876A3 (en) Composition for potentiating vaccination effect
IL77796A (en) Compound named"substance no.51262",process for the preparation thereof,agrochemical composition containing the same and methods for retarding the growth of plants using the same
IE821319L (en) Nematocidal compositions
HUT41211A (en) Insecticide compositions containing alkane derivatives as active substances and process for preparing the active ingredients
IL90004A0 (en) 5-fluoromethyl pyrimidine-2-sulfonamides,process for their preparation and composition for their use as herbicides
AU515571B2 (en) Preparation of cyclo-1,3,2-oxazaphosphoryl derivatives
HUT41228A (en) Microbicide compositions containing new 2,4-dichloro-5-nitro-thiazole as active ingredient and process for preparing the active substance
AU7790787A (en) Process for the preparation of N,N'-tetrathiodimorpholine
JPS53142976A (en) Preventing method for elution of soluble component